Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|June 27, 2024
Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Promising Screening Biomarkers for Brain Metastases in Patients with Lung CancerSu-Hyun Kim, Beung-Chul Ahn, Dong-Eun Lee, et al.
JAMA Oncology|November 26, 2025
Lorlatinib in Tyrosine Kinase Inhibitor-Naive Advanced ROS1-Positive Non-Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical TrialBeung Chul Ahn, Yu Jung Kim, Youngjoo Lee, et al.
Cancers|July 2, 2021
Distinct Characteristics and Clinical Outcomes to Predict the Emergence of <i>MET</i> Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsBeung-Chul Ahn, Ji Hyun Lee, Min Hwan Kim, et al.
Cancer Research and Treatment|June 21, 2023
Tumor Microenvironment Modulation by Neoadjuvant Erlotinib Therapy and Its Clinical Impact on Operable EGFR-Mutant Non-Small Cell Lung CancerBeung-Chul Ahn, Charny Park, Moon Soo Kim, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 31, 2023
Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancerNamhee Yu, Mihwa Hwang, Youngjoo Lee, et al.
Journal of Cancer Research and Clinical Oncology|March 27, 2019
Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practiceBeung-Chul Ahn, Kyoung-Ho Pyo, Chun-Feng Xin, et al.
Medcomm|August 22, 2025
VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung CancerSehwa Hong, Namhee Yu, Ju Young Cho, et al.
Cancers|December 9, 2023
Treatment Outcomes of Proton Beam Therapy for Esophageal Squamous Cell Carcinoma at a Single InstituteEun Sang Oh, Sung Ho Moon, Youngjoo Lee, et al.
Cancers|September 28, 2023
Nivolumab after Induction Chemotherapy in Previously Treated Non-Small-Cell Lung Cancer Patients with Low PD-L1 ExpressionBeung-Chul Ahn, Charny Park, Sang-Jin Lee, et al.
Oncoimmunology|June 26, 2024
A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)Dong Ki Lee, Sook Ryun Park, Yeul Hong Kim, et al.
Pageof 4